[1]
N. A. Halboos and R. A. . Alasady, “Assessment of Serum Interleukin-23 as a Biomarker for Diagnosis and Disease Activity Evaluation in Ankylosing Spondylitis Patients”, Kufa Jour. Bio., vol. 17, no. 2, pp. 138–147, Aug. 2025, doi: 10.36320/ajb/v17.i2.20076.